Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score
Osteoarthritis is the most prevalent arthritic disease and a leading cause of disability. The pathogenesis of osteoarthritis involves multiple etiologies, including variable degree of synovial inflammation. Metformin and pioglitazone could potentially reduce the levels and activity of inflammatory m...
Main Authors: | Mohammed M. Mohammed, Kassim J. Al-Shamma, Nizar A. Jassim |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy University of Baghdad
2017-03-01
|
Series: | Iraqi Journal of Pharmaceutical Sciences |
Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/384 |
Similar Items
-
Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score
by: Mohammed M. Mohammed, et al.
Published: (2017-02-01) -
Curcumin as adjuvant therapy to Meloxicam in treatment of patients with knee Osteoarthritis; Evaluation of antioxidant activity
by: Maiss Saadi Baqer, et al.
Published: (2020-06-01) -
The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis
by: Roos Ewa M, et al.
Published: (2003-11-01) -
Patient-Reported Outcome Measure of Knee Function: Knee Injury and Osteoarthritis Outcome Score (KOOS)
by: Gi-Wook Kim
Published: (2023-12-01) -
Commentary: Scoring Flaw in the Persian Version of Knee Injury and Osteoarthritis Outcome Score: A comment on “Validation of a Persian-version of Knee injury and Osteoarthritis Outcome Score (KOOS) in Iranians with knee injuries. Osteoarthritis Cartilage 2008 Oct;16(10):1178-82”
by: Zahra Sadat Rezaeian
Published: (2021-04-01)